Federal Spending on Off-Patent Drugs That Lack Generic Competition

J Gen Intern Med. 2021 Mar;36(3):821-823. doi: 10.1007/s11606-020-05752-y. Epub 2020 Mar 6.

Benjamin N Rome^{1

2}, Aaron S Kesselheim^{3

4}

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. brome@bwh.harvard.edu.
² Harvard Medical School, Boston, MA, USA. brome@bwh.harvard.edu.
³ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
⁴ Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types